BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23065429)

  • 1. p53 Arg72Pro polymorphism, HPV status and initiation, progression, and development of cervical cancer: a systematic review and meta-analysis.
    Habbous S; Pang V; Eng L; Xu W; Kurtz G; Liu FF; Mackay H; Amir E; Liu G
    Clin Cancer Res; 2012 Dec; 18(23):6407-15. PubMed ID: 23065429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
    Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
    Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53 codon 72 polymorphism, human papillomavirus infection, and their interaction to oral carcinoma susceptibility.
    Hou J; Gu Y; Hou W; Wu S; Lou Y; Yang W; Zhu L; Hu Y; Sun M; Xue H
    BMC Genet; 2015 Jun; 16():72. PubMed ID: 26123760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
    Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of p53 codon 72 polymorphism and its association with human papillomavirus 16 and 18 E6 in Chinese cervical lesions.
    Min-min H; Ming-rong X; Ze-yi C; Kai-xuan Y; Zhi-lin S
    Int J Gynecol Cancer; 2006; 16(6):2004-8. PubMed ID: 17177838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer.
    Madeleine MM; Shera K; Schwartz SM; Daling JR; Galloway DA; Wipf GC; Carter JJ; McKnight B; McDougall JK
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):225-7. PubMed ID: 10698487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Codon 72 polymorphism of p53 and HPV type 16 E6 variants as risk factors for patients with squamous epithelial lesion of the uterine cervix.
    Burroni E; Bisanzi S; Sani C; Puliti D; Carozzi F
    J Med Virol; 2013 Jan; 85(1):83-90. PubMed ID: 23124863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV 16-E6-mediated degradation of intrinsic p53 is compensated by upregulation of p53 gene expression in normal cervical keratinocytes.
    Kawamata Y; Mitsuhashi A; Unno Y; Kado S; Shino Y; Uesugi K; Eguchi O; Ishii J; Seki K; Sekiya S; Shirasawa H
    Int J Oncol; 2002 Sep; 21(3):561-7. PubMed ID: 12168100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between p53 Arg72Pro polymorphism and cervical carcinoma in Uigur and Han women in Xinjiang].
    Zheng XZ; Yang AQ; Pan XL; Zheng LL; Zhou QY; Li XM; Wang XL; Yan LH; Li HA
    Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):511-5. PubMed ID: 17980096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer.
    Dokianakis DN; Spandidos DA
    Mol Cell Biol Res Commun; 2000 Feb; 3(2):111-4. PubMed ID: 10775508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India.
    Katiyar S; Thelma BK; Murthy NS; Hedau S; Jain N; Gopalkrishna V; Husain SA; Das BC
    Mol Cell Biochem; 2003 Oct; 252(1-2):117-24. PubMed ID: 14577584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 polymorphism at codon 72--does it constitute a risk for squamous intraepithelial lesions and invasive cancer of the cervix in Central Europeans?
    Kucera E; Tong D; Reinthaller A; Leodolter S; Zeillinger R; Sliutz G
    Wien Klin Wochenschr; 2000 Sep; 112(18):817-20. PubMed ID: 11072671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India.
    Pillai MR; Sreevidya S; Pollock BH; Jayaprakash PG; Herman B
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):627-31. PubMed ID: 12458344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation.
    Makni H; Franco EL; Kaiano J; Villa LL; Labrecque S; Dudley R; Storey A; Matlashewski G
    Int J Cancer; 2000 Aug; 87(4):528-33. PubMed ID: 10918193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of HPV-16 genome status of the lymph nodes, the integration status and p53 genotype in HPV-16 positive cervical cancer: a long term follow up.
    Hernádi Z; Szarka K; Sápy T; Krasznai Z; Veress G; Póka R
    BJOG; 2003 Feb; 110(2):205-9. PubMed ID: 12618167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of human papillomavirus DNA, serum p53, and p53 antibodies in patients with cervical cancer.
    Sobti RC; Parashar K; Kaur R; Capalash N
    J Environ Pathol Toxicol Oncol; 2002; 21(1):79-85. PubMed ID: 11934017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between P53 codon 72 polymorphism and tumorigenesis of cervical cancer].
    Li CY; Liu JH; Huang BJ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1396-9. PubMed ID: 15566643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China.
    Li T; Lu ZM; Guo M; Wu QJ; Chen KN; Xing HP; Mei Q; Ke Y
    Cancer; 2002 Dec; 95(12):2571-6. PubMed ID: 12467072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 at codon 72 polymorphism, human papillomavirus infection and cervical lesions: a cross-sectional study from northeastern Italy.
    Comar M; Molin GD; Guaschino S; Campello C
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):210-4. PubMed ID: 15140517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.